Addison Disease
Welcome,         Profile    Billing    Logout  
 6 Companies   4 Products   4 Products   3 Mechanisms of Action   0 Trials   13 News 
  • ||||||||||  prednisone / Generic mfg.
    Trial completion, Trial initiation date, Trial primary completion date:  Vapreda: Vaginal Prednisone Administration for Prevention of Adrenal Crisis (clinicaltrials.gov) -  May 30, 2017   
    P2,  N=12, Completed, 
    Recruiting --> Completed | N=50 --> 89 | Trial primary completion date: Sep 2015 --> Jun 2016 Not yet recruiting --> Completed | Initiation date: Apr 2016 --> Jan 2017 | Trial primary completion date: Oct 2016 --> Apr 2017
  • ||||||||||  Solu-Cortef (hydrocortisone sodium succinate injection) / Pfizer
    Trial completion, Enrollment change:  Continuous Subcutaneous Hydrocortisone Infusion In Addison's Disease and Type 1 Diabetes (clinicaltrials.gov) -  Dec 30, 2016   
    P2,  N=2, Completed, 
    Not yet recruiting --> Completed | Initiation date: Apr 2016 --> Jan 2017 | Trial primary completion date: Oct 2016 --> Apr 2017 Active, not recruiting --> Completed | N=10 --> 2
  • ||||||||||  Trial completion, Trial initiation date:  Adrenal Function After Living Kidney Donation (clinicaltrials.gov) -  Dec 29, 2016   
    P=N/A,  N=30, Completed, 
    Active, not recruiting --> Completed | N=10 --> 2 Recruiting --> Completed | Initiation date: Dec 2005 --> Jan 2007
  • ||||||||||  Solu-Cortef (hydrocortisone sodium succinate injection) / Pfizer
    Enrollment closed, Trial primary completion date:  Continuous Subcutaneous Hydrocortisone Infusion In Addison's Disease and Type 1 Diabetes (clinicaltrials.gov) -  Dec 4, 2015   
    P2,  N=10, Active, not recruiting, 
    Recruiting --> Completed | Initiation date: Dec 2005 --> Jan 2007 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Dec 2016
  • ||||||||||  Solu-Cortef (hydrocortisone sodium succinate injection) / Pfizer
    Trial primary completion date:  Continuous Subcutaneous Hydrocortisone Infusion In Addison's Disease and Type 1 Diabetes (clinicaltrials.gov) -  Apr 14, 2015   
    P2,  N=10, Recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Dec 2016 Trial primary completion date: Jun 2014 --> Dec 2015
  • ||||||||||  Solu-Cortef (hydrocortisone sodium succinate injection) / Pfizer
    Trial completion:  Glucocorticoid Treatment in Addison's Disease (clinicaltrials.gov) -  Mar 18, 2013   
    P2/3,  N=33, Completed, 
    N=500 --> 0 Active, not recruiting --> Completed
  • ||||||||||  Synacthen Depot (cosyntropin) / Novartis, Mallinckrodt, Alliance
    Trial completion:  RoSA: Revival of Stem Cells in Addison's Study (clinicaltrials.gov) -  Feb 4, 2013   
    P4,  N=13, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed